References
- Leor J, Poole WK, Kloner RA. Sudden cardiac death triggered by an earthquake. N Engl J Med. 1996;334:413–419.
- Nishimoto Y, Firth BR, Kloner RA, et al. The 1994 northridge earthquake triggered shocks from implantable cardioverter defibrillators. Circulation. 1995;92(SupplI):I–606.
- Zhang XQ, Chen M, Yang Q, et al. Effect of the Wenchuan earthquake in China on hemodynamically unstable ventricular tachyarrhythmia in hospitalized patients. Am J Cardiol. 2009 Apr 1;103(7):994–997..
- Chan C, Elliott J, Troughton R, et al. Acute myocardial infarction and stress cardiomyopathy following the Christchurch earthquakes. PLoS One. 2013;8(7):e68504. Published 2013 Jul 2..
- Secon H, Woodward A, Mosher D A comprehensive timeline of the new coronavirus pandemic, from China’s first COVID-19 case to the present. Business Insider. https://www.businessinsider.com/coronavirus-pandemic-timeline-history-major-events-2020-3
- World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. February 11, 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it
- Johns Hopkins University & Medicine Coronavirus Resource Center. Coronavirus COVID-19 global cases by the center for systems science and engineering. https://coronavirus.jhu.edu/map.html
- Mattioli AV, Ballerini Puviani M, Nasi M, et al. COVID-19 pandemic: the effects of quarantine on cardiovascular risk. Eur J Clin Nutr. 2020. (In press). doi:10.1038/s41430-020-0646-z.
- Mattioli AV, Nasi M, Cocchi C, et al. COVID 19 outbreak: impact of the quarantine-induced stress on cardiovascular disease risk burden. Future Cardiol. 2020 Apr. Published online 2020 Apr 30. doi: 10.2217/fca-2020-0055. Doi:10.2217/fca-2020-0055.
- Baldi E, Sechi GM, Mare C, et al. Out-of-hospital cardiac arrest during the COVID-19 outbreak in Italy. N Engl J Med. 2020 April 29. DOI:10.1056/NEJMc2010418.
- De Filippo O, D’Ascenzo F, Angelini F, et al. Reduced rate of hospital admissions for ACS during Covid-19 outbreak in Northern Italy. N Eng J Med. 2020 Apr 28. DOI:10.1056/NEJMc2009166.
- Metzler B, Siostrzonek P, Binder RK, et al. Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage. Eur Heart J. 2020 Apr 16. DOI:10.1093/eurheartj/ehaa314.
- Cosentino N, Assanelli E, Merlino L, et al. an in-hospital pathway for acute coronary syndrome patients during the COVID-19 outbreak: initial experience under real-world suboptimal conditions [published online ahead of print, 2020 apr 17]. Can J Cardiol. 2020;S0828-282X(20)30396–2. DOI:10.1016/j.cjca.2020.04.011
- Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial [published online ahead of print, 2020 Mar 20]. Int J Antimicrob Agents. 2020;105949. DOI:10.1016/j.ijantimicag.2020.105949
- American College of Cardiology. Ventricular arrhythmia risk due to hydroxychloroquine-azithromycin treatment for COVID-19. March 29, 2020. [cited 2020 Mar 29]. Available from: https://www.acc.org/latest-in-cardiology/articles/2020/03/27/14/00/ventricular-arrhythmia-risk-due-to-hydroxychloroquine-azithromycin-treatment-for-covid-19
- Chorin E, Dai M, Shulman E, et al. The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin. Nat Med. 2020. DOI:10.1038/s41591-020-0888-2.
- Lazzerini PE, Laghi-Pasini F, Bertolozzi I, et al. Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes. Heart. 2017 Nov;103(22):1821–1829.
- Hancox JC, Hasnain M, Vieweg WV, et al. Azithromycin, cardiovascular risks, QTc interval prolongation, torsade de pointes, and regulatory issues: A narrative review based on the study of case reports. Ther Adv Infect Dis. 2013;1(5):155‐165. DOI: 10.1177/2049936113501816
- Bonow RO, Fonarow GC, O’Gara PT, et al. Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality. JAMA Cardiol. 2020 March 27. Published online. DOI:10.1001/jamacardio.2020.1105.
- Cholankeril G, Podboy A, Aivaliotis VI, et al. High Prevalence of Concurrent Gastrointestinal Manifestations in Patients with SARS-CoV-2: Early Experience from California [published online ahead of print, 2020 Apr 10]. Gastroenterology. 2020;S0016-5085(20)30471-6. DOI:10.1053/j.gastro.2020.04.008